GIA
FRX

Gateway Investment Advisers’s FOREST LABORATORIES INC FRX Stock Holding History

Gateway Investment Advisers’s Portfolio FRX Stock Details FRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-42,108
Closed -$4.17M – 679
2014
Q2 		$4.17M Buy
42,108
+3,840
+10% +$358K 0.03% 318
2014
Q1 		$3.53M Sell
38,268
-261
-0.7% -$21.1K 0.03% 317
2013
Q4 		$2.31M Sell
38,529
-600
-2% -$30.2K 0.02% 381
2013
Q3 		$1.67M Buy
39,129
+1,824
+5% +$79.2K 0.01% 431
2013
Q2 		$1.53M Buy
+37,305
New +$1.44M 0.01% 421

Other funds holding FRX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
CM
Castleark Management Chicago, Illinois $3.02B AUM 53.92% 1-Year Est. Return
OFG
OTA Financial Group Purchase, New York $143M AUM 16.9% 1-Year Est. Return
KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return

Gateway Investment Advisers's FRX Position: Q3 2014 in Review

Gateway Investment Advisers sold out of FOREST LABORATORIES INC (FRX) in Q3 2014, closing a stake of 42,108 shares — an estimated $4.17M sold.

Gateway Investment Advisers first reported a position in FRX in Q2 2013 and held it in 5 quarters. The position peaked at $4.17M in Q2 2014. 5 funds tracked by Wall St. Rank hold FRX as of Q3 2014.

  • Gateway Investment Advisers reported no remaining FOREST LABORATORIES INC position as of Q3 2014 after selling out during the quarter.
  • Gateway Investment Advisers sold 42,108 FOREST LABORATORIES INC shares in Q3 2014, an estimated $4.17M.
  • Gateway Investment Advisers first reported a position in FOREST LABORATORIES INC in Q2 2013 and held it in 5 quarters.
  • Gateway Investment Advisers's FOREST LABORATORIES INC position peaked at $4.17M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held FOREST LABORATORIES INC as of Q3 2014.

Based on Gateway Investment Advisers's 13F filing for Q3 2014, filed 10 Oct 2014.